Napa Wealth Management trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 75.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 751 shares of the medical equipment provider's stock after selling 2,298 shares during the period. Napa Wealth Management's holdings in Intuitive Surgical were worth $392,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Atala Financial Inc bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $25,000. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $26,000. Parvin Asset Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $28,000. Finally, Hurley Capital LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $28,000. 83.64% of the stock is currently owned by institutional investors.
Intuitive Surgical Price Performance
Shares of ISRG stock traded up $3.32 during trading hours on Friday, reaching $563.60. The company had a trading volume of 1,422,176 shares, compared to its average volume of 1,640,855. The company has a 50 day moving average of $505.22 and a 200 day moving average of $536.45. The firm has a market cap of $202.00 billion, a price-to-earnings ratio of 87.93, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 1-year low of $393.98 and a 1-year high of $616.00.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the prior year, the business posted $1.50 EPS. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.
Insider Activity at Intuitive Surgical
In related news, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the sale, the director now owns 6,371 shares of the company's stock, valued at approximately $3,312,920. This represents a 27.36% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 32,700 shares of company stock worth $16,865,621 in the last quarter. Corporate insiders own 0.70% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts have recently weighed in on the company. Royal Bank of Canada lowered their price objective on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Leerink Partners boosted their target price on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Barclays reduced their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Raymond James boosted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Finally, Erste Group Bank downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $598.95.
Get Our Latest Analysis on ISRG
Intuitive Surgical Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.